Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-12 Sale | 2024-02-13 5:06 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 781 | $67.77 | $52,926 | 194,095 (Indirect Direct) | View |
| 2024-01-29 Sale | 2024-01-31 4:38 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 906 | $64.14 | $58,109 | 194,876 (Indirect Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:17 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 4,184 | $65 | $271,943 | 195,782 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:38 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 4,240 | $66.81 | $283,268 | 234,499 (Indirect Direct) | View |
| 2023-12-19 Sale | 2023-12-20 4:18 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,905 | $57.23 | $223,472 | 184,220 (Indirect Direct) | View |
| 2023-07-03 Sale | 2023-07-06 4:20 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 8,510 | $89.98 | $765,730 | 176,458 (Indirect Direct) | View |
| 2022-06-22 Sale | 2022-06-23 4:22 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 10,000 | $44.51 | $445,140 | 125,569 (Indirect Direct) | View |
| 2022-04-25 Sale | 2022-04-27 4:39 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $50 | $250,000 | 137,444 (Indirect Direct) | View |
| 2021-12-27 Sale | 2021-12-28 5:38 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 1,200 | $48.5 | $58,200 | 117,534 (Indirect Direct) | View |
| 2021-12-22 Sale | 2021-12-23 4:58 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 10,571 | $47.81 | $505,373 | 182,067 (Indirect Direct) | View |
| 2020-12-11 Sale | 2020-12-15 4:03 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 18,333 | $50.94 | $933,947 | 105,136 (Indirect Direct) | View |
| 2020-02-10 Sale | 2020-02-12 4:38 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $44.5 | $222,500 | 91,172 (Indirect Direct) | View |
| 2020-01-27 Sale | 2020-01-28 5:08 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,000 | $40.47 | $121,401 | 51,547 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-06 Exercise | 2024-03-08 07:45 am | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,762 | $0 | 197,857 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 07:45 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,762 | $13.85 | 197,857 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:38 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 34,533 | $66.3 | 234,499 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:38 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 23,748 | $0 | 234,499 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-20 4:18 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,905 | $0 | 184,220 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-20 4:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,905 | $13.85 | 184,220 (Direct) | View |
| 2023-06-28 Gift | 2023-06-29 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 12,750 | $0 | 184,968 (Direct) | View |
| 2023-04-21 Gift | 2023-04-24 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 67,955 | $0 | 184,968 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:42 am | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 23,909 | $0 | 198,991 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:42 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 825 | $58.5 | 198,991 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 5:29 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 532 | $51.21 | 175,907 (Direct) | View |
| 2023-01-27 Tax Withholding | 2023-01-30 5:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 551 | $52.77 | 176,439 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 5:33 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 2,034 | $52.05 | 176,990 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:46 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 37,708 | $52.66 | 216,732 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:46 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 53,455 | $0 | 216,732 (Direct) | View |
| 2022-04-21 Other | 2022-04-27 4:39 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 13,125 | $0 | 137,444 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 6:36 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 491 | $47.12 | 142,444 (Direct) | View |
Ownership | 2022-02-10 4:51 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 0 | $0 | 10,000 (Indirect) | View |
| 2021-12-08 Ownership | 2022-02-10 4:51 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,333 | $0 | 10,000 (Direct) | View |
| 2022-01-28 Tax Withholding | 2022-02-01 6:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 650 | $38.59 | 142,935 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:49 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 63,002 | $0 | 180,536 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:58 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 20,112 | $0 | 182,067 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 10,112 | $14.95 | 182,067 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 10,000 | $13.85 | 182,067 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-13 4:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 954 | $4.31 | 109,193 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-13 4:08 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 954 | $0 | 109,193 (Direct) | View |
| 2021-06-21 Exercise | 2021-06-22 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 489 | $4.31 | 109,193 (Direct) | View |
| 2021-06-21 Exercise | 2021-06-22 4:02 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 489 | $0 | 109,193 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 4:53 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 489 | $4.31 | 109,193 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 4:53 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 489 | $0 | 109,193 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-23 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 489 | $4.31 | 109,193 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-23 4:02 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 489 | $0 | 109,193 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-23 4:14 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 978 | $4.31 | 109,193 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-23 4:14 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 978 | $0 | 109,193 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 468 | $47.72 | 105,794 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:40 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 65,625 | $0 | 162,512 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 20,042 | $4.31 | 100,286 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A 2026-02-06 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 43,483 | $0 | 100,286 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 23,441 | $3.76 | 100,286 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 4:03 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 18,333 | $0 | 105,136 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 4:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 18,333 | $13.85 | 105,136 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 4:38 pm | N/A 2023-12-31 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,505 | $0 | 91,172 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:38 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 44,625 | $0 | 91,172 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 4:38 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,505 | $2.67 | 91,172 (Direct) | View |
| 2020-01-27 Exercise | 2020-01-28 5:08 pm | N/A 2023-12-29 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 15,000 | $0 | 51,547 (Direct) | View |
| 2020-01-27 Exercise | 2020-01-28 5:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 15,000 | $2.67 | 51,547 (Direct) | View |
| 2019-08-07 Exercise | 2019-08-09 08:48 am | N/A 2023-12-31 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $0 | 54,547 (Direct) | View |
| 2019-08-07 Exercise | 2019-08-09 08:48 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $2.67 | 54,547 (Direct) | View |